(SUPN) Supernus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Supernus Pharmaceuticals | (SUPN) share price targets
Complete technical analysis of Supernus Pharmaceuticals (SUPN) by charts plus indicators, forecast predictions and share price targets for Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-04-03 View latest technical analysis
10 day averaged volume of Supernus Pharmaceuticals is 452070
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Wed Apr 2024 | 33.85 | 32.85 | 34.07 | 32.82 | 0.684 times |
| 02 Tue Apr 2024 | 33.17 | 33.23 | 33.61 | 32.77 | 0.672 times |
| 01 Mon Apr 2024 | 33.52 | 34.10 | 34.10 | 33.06 | 0.522 times |
| 28 Thu Mar 2024 | 34.11 | 33.84 | 34.39 | 33.47 | 1.086 times |
| 27 Wed Mar 2024 | 33.74 | 32.85 | 33.83 | 32.56 | 0.805 times |
| 26 Tue Mar 2024 | 32.48 | 32.99 | 33.59 | 32.29 | 1.353 times |
| 25 Mon Mar 2024 | 32.75 | 34.73 | 34.98 | 32.57 | 0.811 times |
| 22 Fri Mar 2024 | 34.52 | 35.15 | 35.22 | 33.97 | 1.09 times |
| 21 Thu Mar 2024 | 35.17 | 35.05 | 35.44 | 34.68 | 0.964 times |
| 20 Wed Mar 2024 | 34.88 | 35.13 | 35.35 | 34.50 | 0.969 times |
My analysis of stock is bullish for shortterm, and stock might move up till 34.6 or till 36.2. Use a stoploss of 33.34 and if this stock hits its stoploss, then it can fall down till 32.06
Share price targets for Supernus Pharmaceuticals (SUPN)
| Target Type | Value |
| Downside Target | 26.13 |
| Downside Target | 29.78 |
| Downside Target | 30.88 |
| Downside Target | 32.00 |
| Downside Target | 32.77 |
| Upside Target | 34.10 |
| Upside Target | 34.83 |
| Upside Target | 34.98 |
| Upside Target | 35.44 |
Intraday share price targets for Supernus Pharmaceuticals (SUPN)
| Target Type | Value |
| Downside Intraday Target | 33.05 |
| Downside Intraday Target | 32.24 |
| Upside Intraday Target | 34.38 |
| Upside Intraday Target | 34.9 |
| Downside Intraday Target | 33.57 |
Weekly technical analysis of Supernus Pharmaceuticals (SUPN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Wed Apr 2024 | 33.85 | 34.10 | 34.10 | 32.77 | 0.463 times |
| 28 Thu Mar 2024 | 34.11 | 34.73 | 34.98 | 32.29 | 0.711 times |
| 22 Fri Mar 2024 | 34.52 | 33.15 | 35.44 | 32.55 | 0.918 times |
| 15 Fri Mar 2024 | 32.98 | 31.16 | 34.83 | 30.88 | 1.476 times |
| 08 Fri Mar 2024 | 31.07 | 30.96 | 32.00 | 29.78 | 0.57 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Supernus Pharmaceuticals (SUPN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Wed Apr 2024 | 33.85 | 34.10 | 34.10 | 32.77 | 0.089 times |
| 28 Thu Mar 2024 | 34.11 | 30.00 | 35.44 | 29.78 | 1.336 times |
| 29 Thu Feb 2024 | 29.70 | 27.80 | 32.30 | 26.27 | 0.992 times |
| 31 Wed Jan 2024 | 27.68 | 28.85 | 29.99 | 26.47 | 0.921 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Supernus Pharmaceuticals (SUPN)
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term but the sell signal is initial and weak.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Supernus Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Supernus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 33.83 and Supernus Pharmaceuticals (SUPN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term but the sell signal is initial and weak.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Supernus Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Supernus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 33.83 and Supernus Pharmaceuticals (SUPN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.